Basket | Login | Register

 
 
 
 

ELAD (coming soon)

Phase II trials

Scientific title

Evaluating Liraglutide in Alzheimer's Disease

Study sponsor

University College London

Disease

Mild Alzheimer's dementia

Phase

Phase II

Name of drug

Liraglutide

Link to full text

https://clinicaltrials.gov/ct2/show/NCT01843075

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Thursday 07 February 2019

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options